Methods of preventing or treating inflammatory or autoimmune disorders by administering integrin alphav Beta3 antagonists

Details for Australian Patent Application No. 2002306651 (hide)

Owner Medimmune, Inc.

Inventors Wilder, Ronald; Dingivan, Christine

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2002306651

PCT Number PCT/US02/06679

PCT Pub. Number WO2002/070007

Priority 60/346,918 19.10.01 US; 60/316,321 31.08.01 US; 60/358,424 19.02.02 US; 60/273,098 02.03.01 US

Filing date 4 March 2002

Wipo publication date 19 September 2002

Acceptance publication date 13 December 2007

International Classifications

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 31/121 (2006.01) - acyclic

A61K 31/164 (2006.01) - of a carboxylic acid with an aminoalcohol, e.g. ceramides

A61K 31/192 (2006.01)

A61K 31/196 (2006.01)

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61K 31/616 (2006.01)

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 1/04 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 11/06 (2006.01) Drugs for disorders of the respiratory system

A61P 19/02 (2006.01) Drugs for skeletal disorders

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

A61P 37/08 (2006.01) Drugs for immunological or allergic disorders

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07K 16/24 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

Event Publications

19 December 2002 Complete Application Filed

  Priority application(s): 60/346,918 19.10.01 US; 60/316,321 31.08.01 US; 60/358,424 19.02.02 US; 60/273,098 02.03.01 US

13 March 2003 Application Open to Public Inspection

  Published as AU-B-2002306651

13 December 2007 Application Accepted

  Published as AU-B-2002306651

17 April 2008 Standard Patent Sealed

9 October 2008 Alteration of Name

  The name of the patentee has been altered to MedImmune, LLC

1 October 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002306652-METHOD FOR ADMINISTERING A CREDIT CARD WITH A FINANCE WAIVER PERIOD

2002306650-HIGH POWER DENSITY SOLID OXIDE FUEL CELLS AND METHOD OF FABRICATION